Charles River Laboratories <CRL.N>: Deutsche Bank Raises Target Price to $300 From $260
CRL•Related News
Annexon says tanruprubart shows rapid strength gains in first 10 GBS FORWARD study patients
ANNX•
Principal Asset Management names Daniel Maric head of European distribution
PFG•
Kingsoft Cloud to release Q2 2026 results before US market open
KC•
Zhengye Biotechnology regains Nasdaq compliance with $1 minimum bid price rule
ZYBT•
Iovance publishes corporate presentation highlighting Amtagvi TIL therapy rollout and pipeline expansion in solid tumors
IOVA•